Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.
about
A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress SyndromePlasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.Gap junction protein connexin43 exacerbates lung vascular permeabilityElevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis.Preventing ARDS: progress, promise, and pitfallsCytokines and clinical predictors in distinguishing pulmonary transfusion reactions.Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation.The association between the Th-17 immune response and pulmonary complications in a trauma ICU populationRecent insight into potential acute respiratory distress syndromeElevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort study.Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS.IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositisTreatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways.Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction.Biological therapies in the acute respiratory distress syndrome.Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care.Pathophysiology and biomarkers of acute respiratory distress syndrome.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome.Proteomic study of acute respiratory distress syndrome: current knowledge and implications for drug development.Serial inflammatory biomarkers of the severity, course and outcome of late onset acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new-onset fever.Higher mini-BAL total protein concentration in early ARDS predicts faster resolution of lung injury measured by more ventilator-free days.Ventilator-induced Lung Injury.
P2860
Q26765351-7D7E116F-7B70-4A29-A404-B81169D4C8BAQ30360456-76EC3FE4-36F3-4512-A3BD-CF2C2177E61AQ33812506-30851D20-7BE9-4E0A-A82B-C45D1FF7C347Q34021204-3C436548-5303-4230-B319-FAA12C448FF6Q34299807-8C4FD015-9BF8-40F1-9EC1-FCC40CF6765CQ35952205-041D774D-0581-4181-8FF5-08B46E060692Q36221294-ECC57DC8-6C82-41D5-8E75-297186219AE1Q36248035-B1163AF9-B5B0-4B57-8F38-D36AFC7E5A6AQ36342998-594078FF-4BB2-44CA-A7D8-217D5724F82DQ36424706-59C0305C-0278-4AAC-A5E9-826628815F61Q36751000-B103B086-BCB1-43A9-9930-17185DA93F6EQ37706152-B319E38E-408A-4A5D-A46E-CD8F5FB55079Q37714536-C34EE1EE-0D45-4838-A2E1-2E8FA871FF75Q38101107-1CBA9F0D-3A9E-43D0-A55E-48587C2F872FQ38138015-2212462E-BE31-48AD-8E20-0A156BBC3E0EQ38202165-7433272C-221A-4BD0-A1DC-28F95C90FC3FQ38215937-348421CF-DE45-41C7-B477-454A42B88D62Q38292758-5C075A13-FDEC-4168-8698-824CF126BA99Q38552059-3CC99A86-88B1-4B00-928A-B0BEBF86E81AQ38751954-6F61BAE1-9764-4A17-B1F2-7AB50A5E0E4DQ38887825-5C09026E-5EBC-4A0A-B22F-D9E5AA40D858Q40151360-73DB1200-C674-4211-AFE9-AF25FA74655AQ47328997-737DC1DF-46A7-464F-B839-CEDF0ACA5F50Q51420387-281605A3-5972-4E99-B1B5-388B44385B35
P2860
Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pathogenetic and predictive va ...... ults from two clinical trials.
@ast
Pathogenetic and predictive va ...... ults from two clinical trials.
@en
type
label
Pathogenetic and predictive va ...... ults from two clinical trials.
@ast
Pathogenetic and predictive va ...... ults from two clinical trials.
@en
prefLabel
Pathogenetic and predictive va ...... ults from two clinical trials.
@ast
Pathogenetic and predictive va ...... ults from two clinical trials.
@en
P2093
P2860
P1476
Pathogenetic and predictive va ...... ults from two clinical trials.
@en
P2093
Ashish Agrawal
Graciela Soto
Hanjing Zhuo
Jay Steingrub
Joseph Levitt
Kathleen D Liu
Mark D Siegel
Mark S Chesnutt
Michael W Peterson
Sandra Brady
P2860
P304
P356
10.1152/AJPLUNG.00195.2012
P577
2012-08-03T00:00:00Z